Tumor Necrosis Factor Inhibitors and the Risk of Malignancy in the Treatment of Juvenile Idiopathic Arthritis

被引：0
|
作者：
Beukelman, Timothy [1 ]
Xie, Fenglong [2 ]
Chen, Lang [2 ]
Horton, Daniel [3 ]
Lewis, James D. [4 ]
Mamtani, Ronac [4 ]
Mannion, Melissa [5 ]
Saag, Kenneth G. [2 ]
Zhang, Jie [6 ]
Curtis, Jeffrey R. [2 ]
机构：
[1] Univ Alabama Birmingham, Pediat Rheumatol, Birmingham, AL USA
[2] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL USA
[3] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Univ Alabama Birmingham, Pediat, Birmingham, AL USA
[6] Univ Alabama Birmingham, Epidemil, Birmingham, AL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2982
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Tumor necrosis factor alpha promoter polymorphisms in patients with juvenile idiopathic arthritis
    Schmeling, H
    Wagner, U
    Peterson, A
    Horneff, G
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (01) : 103 - 108
  • [22] Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
    S Bayraktar
    O Kasapcopur
    N Arisoy
    B Batar
    M Guven
    [J]. Pediatric Rheumatology, 6 (Suppl 1)
  • [23] The Risk of Malignancy Associated with Use of Tumor Necrosis Factor Inhibitors in Childhood
    Beukelman, Timothy
    Xie, Fenglong
    Chen, Lang
    Horton, Daniel B.
    Lewis, James D.
    Mamtani, Ronac
    Mannion, Melissa
    Saag, Kenneth G.
    Curtis, Jeffrey R.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 222 - 222
  • [24] Juvenile idiopathic arthritis and malignancy
    Ruperto, Nicolino
    Martini, Alberto
    [J]. RHEUMATOLOGY, 2014, 53 (06) : 968 - 974
  • [25] Dermatomyositis Induced by Anti-Tumor Necrosis Factor in a Patient With Juvenile Idiopathic Arthritis
    Liu, Stephanie W.
    Velez, Nicole F.
    Lam, Christina
    Femia, Alisa
    Granter, Scott R.
    Townsend, Henry B.
    Vleugels, Ruth Ann
    [J]. JAMA DERMATOLOGY, 2013, 149 (10) : 1204 - 1208
  • [26] Genotoxicity of Anti-Tumor Necrosis Factor Therapy in Patients With Juvenile Idiopathic Arthritis
    Demirkaya, Erkan
    Cok, Ismet
    Durmaz, Emre
    Ulutas, Onur K.
    Ayaz, Nuray Aktay
    Besbas, Nesrin
    Ozen, Seza
    [J]. ARTHRITIS CARE & RESEARCH, 2010, 62 (01) : 73 - 77
  • [27] Tumor necrosis factor alpha promotor polymorphisms in subtypes of juvenile idiopathic arthritis.
    Schmeling, H
    Horneff, G
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S474 - S475
  • [28] Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis
    Lee, Wan-Ju
    Lee, Todd A.
    Suda, Katie J.
    Calip, Gregory S.
    Briars, Leslie
    Schumock, Glen T.
    [J]. RHEUMATOLOGY, 2018, 57 (02) : 273 - 282
  • [29] Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis
    Ljung, Lotta
    Simard, Julia F.
    Jacobsson, Lennart
    Rantapaa-Dahlqvist, Solbritt
    Askling, Johan
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (01): : 42 - 52
  • [30] A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors
    Heather M. Walters
    Nancy Pan
    Thomas J. A. Lehman
    Alexa Adams
    Wei-Ti Huang
    Lemonia Sitaras
    Susanna Cunningham-Rundles
    Thomas J. Walsh
    Sima S. Toussi
    [J]. Clinical Rheumatology, 2015, 34 : 457 - 464
12345